Keratitis Due to Fusarium langsethiae: Clinical Profile, Molecular Identification, and Susceptibility to Antifungals

Mycopathologia

Volumn 179, Issue 5-6, 2015, Pages 453-458

  Vasantha Ruban, Vasanthakumar ^a   Geraldine, Pitchairaj ^a   Kaliamurthy, Jayaraman ^b   Jesudasan, Christadoss Arul Nelson ^b   Thomas, Philip Aloysius ^b  

^a BHARATHIDASAN UNIVERSITY   (India)

^b JOSEPH EYE HOSPITAL   (India)

Author keywords

Cornea; DNA sequencing; Fusarium; Fusarium langsethiae; Keratitis

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; RIBOSOME DNA; RNA 28S;

CASE REPORT; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; COMPLICATION; CORNEAL ULCER; DNA SEQUENCE; DRUG EFFECTS; EYE INJURY; FUSARIOSIS; FUSARIUM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSCOPY; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PHYLOGENY;

ANTIFUNGAL AGENTS; CLUSTER ANALYSIS; CORNEAL ULCER; DNA, FUNGAL; DNA, RIBOSOMAL; EYE INJURIES; FUSARIOSIS; FUSARIUM; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MICROSCOPY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 28S; SEQUENCE ANALYSIS, DNA;

EID: 84939974278     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-015-9866-5     Document Type: Article

References (13)

1. Guarro J, Rubio C, Gene J, et al. Case of keratitis caused by an uncommon Fusarium species. J Clin Microbiol. 2003;41:5823–6.
2. Torp M, Nirenberg HI. Fusarium langsethiae sp. nov. on cereals in Europe. Int J Food Microbiol. 2004;95:247–56.
3. Kumar M, Mishra NK, Shukla PK. Sensitive and rapid polymerase chain reaction based diagnosis of mycotic keratitis through single stranded conformation polymorphism. Am J Ophthalmol. 2005;140:851–7.
4. Shadomy S, Espinel-Ingroff A, Cartwright RY. Laboratory studies with antifungal agents: susceptibility tests and bioassays. In: Lennette EH, Balows A, Hausler WJ, et al., editors. Manual of clinical microbiology. 4th ed. Washington DC: American society for microbiology; 1985. p. 991–9.
5. Nelson PE, Toussoun TA, Marasas WFO. Fusarium species: an illustrated manual for identification. University Park: Pennsylvania State University Press; 1983.
6. Windels CE. Current status of Fusarium taxonomy. Phytopathology. 1991;81:1048–51.
7. Guarro J. Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur J Clin Microbiol Infect Dis. 2013;32:1491–500.
8. Cruickshank R, Duguid JP, Marmion BP, Swain RHA. The enterobacteriaceae Salmonella. Medical microbiology, vol. 11. 12th ed. Edinburgh, London and New York: Churchill Livingstone; 1975. p. 403–19.
9. Van Tyle JH. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984;4:343–73.
10. Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42–7.
11. Nulens E, Eggink C, Rijs AJ, et al. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J Clin Microbiol. 2003;41:2261–4.
12. Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131:422–9.
13. Imathiu SM, Edwards SG, Ray RV, et al. Fusarium langsethiae—a HT2 and T-2 Toxins producer that needs more attention. J Phytopathol. 2013;161:1–10.